Common side effects include pain or discomfort at the injection site, and less commonly, gastrointestinal disturbances, allergic reactions, or other issues
Likewise, individuals undergoing immunosuppressive treatment warrant careful assessment due to potential modulation of immune system activity and tissue repair mechanisms
It is studied in laboratory environments investigating peptide-mediated signaling pathways, cellular responses, and biological processes within controlled experimental systems
No refrigeration is required for the topical serum, though it should be used within 90 days of opening to ensure peptide stability
The products are not medicines or drugs and they have not been approved by the FDA to prevent, treat, diagnose, mitigate, or cure any disease, ailment or medical condition
BPC-157 Concerns FDA states that BPC-157 may present immunogenicity risks for certain routes because of aggregation and peptide-related impurities